Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06169371 |
| Title | Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) (BRE-09) |
| Acronym | BRE-09 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | University of Illinois at Chicago |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Illinois | RECRUITING | Chicago | Illinois | 60612 | United States | Details |
| Iowa Holden Comprehensive Cancer Center | RECRUITING | Iowa City | Iowa | 52242 | United States | Details |